| 產(chǎn)品詳情 |
| Edit |   |
|---|
| Product Name | SRT-3025 hydrochloride |
|---|
| Description | MW: 606.2, Purity ≥98% by HPLC. SRT-3025 is a potent and selective Sirt1 activator. It inhibits RANKL-induced osteoclast differentiation, fusion and resorptive capacity without affecting osteoclast survival. SRT-3025 inhibits RANKL-induced osteoclastogenesis in bone marrow-derived macrophages (BMMs) by activating AMPK and deacetylating RelA/p65 lysine 310, critical for activation of the NF-κB signaling pathway. |
|---|
| Size | 25 mg |
|---|
| Concentration | n/a |
|---|
| Applications | RUO |
|---|
| Other Names | 5-(3-methoxypropyl)-2-phenyl-N-(2-(6-(pyrrolidin-1-ylmethyl)thiazolo[5,4-b]pyridin-2-yl)phenyl)thiazole-4-carboxamide hydrochloride, SRT3025 HCl |
|---|
| Gene, Accession, CAS # | CAS: 2070015-26-6 |
|---|
| Catalog # | B2376-25 |
|---|
| Price | |
|---|
| Order / More Info | SRT-3025 hydrochloride from BIOVISION, INC. |
|---|
| Product Specific References | n/a |
|---|
| 產(chǎn)品資料 |
|
|